VERV – verve therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Analysts Are Betting On Verve Therapeutics, Inc. (NASDAQ:VERV) With A Big Upgrade This Week [Yahoo! Finance]
Verve Therapeutics, Inc. (NASDAQ: VERV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102 Tue, May 7, 2024, 1:00 PM GMT+2 6 min read 0 In this article: Advertisement Up next CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards? Mon
Form 10-Q Verve Therapeutics, Inc. For: Mar 31
Form 8-K Verve Therapeutics, Inc. For: May 08
Form ARS Verve Therapeutics, Inc. For: Dec 31
Form DEFA14A Verve Therapeutics, Inc.
Form DEF 14A Verve Therapeutics, Inc. For: Jun 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.